This page includes the latest FDA filings for Pulmonx Corporation700 Chesapeake Driveredwood City Ca 94063 Pma Numberp180002 Supplement Numbers020 Date Received02 07 2022 Decision Date03 09 2022 Product Code Njk Advisory Committee Anesthesiology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Pulmonx Corporation700 Chesapeake Driveredwood City, CA 94063 PMA NumberP180002 Supplement NumberS020 Date Received02/07/2022 Decision Date03/09/2022 Product Code NJK Advisory Committee Anesthesiology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No | Zephyr Valve Registry (ZEVR) | 2022-03-09 |